AER: LIVE 2019
Published: 03 December 2019
-
Views:
74 -
Likes:
7
-
Views:
74 -
Likes:
7
-
Up Next
-
22m 51sPart 1 | Session 3 Is It Safe for Me to Run the Marathon?
-
36m 59sPart 2 | Session 1 NOACS – First Among Equals?
-
19m 58sPart 2 | Session 2 Devices Update – What You Need to Know
-
37m 58sPart 3 | Session 1 Persistent AF ablation: State of the Art
-
27m 57sPart 3 | Session 2 Difficult Problems in Device Therapy
-
36m 44sPart 4 | Session 1 AF Ablation – Who, Why, When?
-
26m 2sPart 4 | Session 2 Cardiomyopathy in Perspective
-
24m 58sPart 5 | Session 1 VT ablation in Non-Ischaemic Cardiomyopathy
-
28m 51sPart 5 | Session 2 The Problem with Sudden Cardiac Death
-
25m 41sPart 6 | Session 1 Device management in Britain in 2025
-
24m 56sPart 6 | Session 2 Arrhythmia Management in Britain in 2025
-
22m 57sPart 1 | Session 1 Risk Factor Modification to Improve AF Outcomes Manish Kalla
Overview
Radcliffe Cardiology, in collaboration with The British Heart Rhythm Society and leading open access journal, Arrhythmia & Electrophysiology Review, presents AER: Live, a new event aimed at best supporting the continuous education of health professionals engaged in arrhythmia management in the UK.
Delivered by leading figures from the British electrophysiology fraternity, AER: Live brings together decision-makers and practitioners with the common goal to maximise patient outcomes. AER: Live aims to inform, educate and disseminate best practice on the most pertinent issues from diagnosis and referral pathways, to optimal treatment strategies and the latest drugs and devices in arrhythmia management, supporting both generalist and specialist education. The aim of AER: Live is to host two events per year at various locations around the UK. Look out for news on forthcoming events on RadcliffeCardiology.com
The supporters had no influence on the content
Educational objectives
- Update knowledge on the latest technologies and treatment strategies in arrhythmia management
- Understand the role of healthcare professionals in holistic treatment and outcomes
- Learn best-practice and the latest NHS guidance on referral pathways
More from this programme
Part 1
Beyond Intervention
Part 2
Anticoagulation & Devices (Generalist)
Part 3
Challenges in EP & Devices (Specialist)
Part 4
How to Select the Right Patients (Generalist)
Part 5
Session 3: Ventricular Arrhythmias (Specialist)
Part 6
Visions of the Future
Faculty Biographies
Paulus Kirchhof
Director of the Institute of Cardiovascular Sciences AND Chair in Cardiovascular Medicine
Prof Kirchhof is the Director of the Institute of Cardiovascular Sciences at the University of Birmingham. Prof Kirchhof research includes novel molecular mechanisms of heart disease that can be leveraged to develop personalised treatment approaches to common cardiovascular diseases.